Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/HCTZ vs Valsartan in Hypertension
NCT00170989Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of valsartan, hydrochlorothiazide in hypertension (HTN), sponsored by Novartis. Started Sep 2004; status: completed.
02
Drugs
valsartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00170989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170989.